Patents by Inventor David Kerstein

David Kerstein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of treating cancer in pediatric patients
    Patent number: 11529363
    Abstract: Provided herein are methods for treating cancers (e.g., inflammatory myofibroblastic tumor, anaplastic large cell lymphoma, and neuroblastoma) in pediatric patients using brigatinib, as monotherapy or combination therapy with one or more second therapeutic agents.
    Type: Grant
    Filed: March 18, 2019
    Date of Patent: December 20, 2022
    Inventors: Sharon Bowen, Michael Hanley, David Kerstein, Karthik Venkatakrishnan
  • METHODS OF TREATING CANCER IN PEDIATRIC PATIENTS
    Publication number: 20210000845
    Abstract: Provided herein are methods for treating cancers (e.g., inflammatory myofibroblastic tumor, anaplastic large cell lymphoma, and neuroblastoma) in pediatric patients using brigatinib, as monotherapy or combination therapy with one or more second therapeutic agents.
    Type: Application
    Filed: March 18, 2019
    Publication date: January 7, 2021
    Inventors: Sharon Bowen, Michael Hanley, David Kerstein, Karthik Venkatakrishnan
  • 2-ACETYLNAPHTHO[2,3-B]FURAN -4,9-DIONE FOR USE ON TREATING CANCER
    Publication number: 20200397740
    Abstract: The invention provides naphthofuran compounds, polymorphs of naphthofuran compounds, naphthofuran compounds in particle form, purified compositions that contain one or more naphthofuran compounds, purified compositions that contain one or more naphthofuran compounds in particle form, and methods of using these naphthofuran compounds, polymorphs, purified compositions and/or particle forms to treat subjects in need thereof.
    Type: Application
    Filed: April 7, 2020
    Publication date: December 24, 2020
    Applicant: Sumitomo Dainnipon Pharma Oncology. Inc.
    Inventors: Chiang Jia Li, Wei Li, David Leggett, Youzhi Li, David Kerstein, Matthew Hitron
  • 2-acetylnaphtho[2,3-b]furan -4,9-dione for use on treating cancer
    Patent number: 10543189
    Abstract: The invention provides naphthofuran compounds, polymorphs of naphthofuran compounds, naphthofuran compounds in particle form, purified compositions that contain one or more naphthofuran compounds, purified compositions that contain one or more naphthofuran compounds in particle form, and methods of using these naphthofuran compounds, polymorphs, purified compositions and/or particle forms to treat subjects in need thereof.
    Type: Grant
    Filed: August 16, 2019
    Date of Patent: January 28, 2020
    Assignee: Boston Biomedical, Inc.
    Inventors: Chiang Jia Li, Wei Li, David Leggett, Youzhi Li, David Kerstein, Matthew Hitron
  • 2-ACETYLNAPHTHO[2,3-B]FURAN -4,9-DIONE FOR USE ON TREATING CANCER
    Publication number: 20190388382
    Abstract: The invention provides naphthofuran compounds, polymorphs of naphthofuran compounds, naphthofuran compounds in particle form, purified compositions that contain one or more naphthofuran compounds, purified compositions that contain one or more naphthofuran compounds in particle form, and methods of using these naphthofuran compounds, polymorphs, purified compositions and/or particle forms to treat subjects in need thereof.
    Type: Application
    Filed: August 16, 2019
    Publication date: December 26, 2019
    Inventors: Chiang Jia Li, Wei Li, David Leggett, Youzhi Li, David Kerstein, Matthew Hitron
  • 2-ACETYLNAPHTHO[2,3-B]FURAN -4,9-DIONE FOR USE ON TREATING CANCER
    Publication number: 20160030384
    Abstract: The invention provides naphthofuran compounds, polymorphs of naphthofuran compounds, naphthofuran compounds in particle form, purified compositions that contain one or more naphthofuran compounds, purified compositions that contain one or more naphthofuran compounds in particle form, and methods of using these naphthofuran compounds, polymorphs, purified compositions and/or particle forms to treat subjects in need thereof.
    Type: Application
    Filed: April 9, 2014
    Publication date: February 4, 2016
    Applicant: Boston Biomedical, Inc.
    Inventors: Chiang Jia Li, Wei Li, David Leggett, Youzhi Li, David Kerstein, Matt Hitron